EGFR and lung carcinoma: Besides, the synergistic pretreatment with miR-125a-5p augmented the cytotoxic effect of erlotinib by reducing cellular proliferation, and enhanced the apoptotic effect, thus bypassing the resistance to EGFR-TKIs in lung cancer cells [72].